Single Batch Bioequivalence Paradigm for Orally Inhaled Products: Time for Change

E-ISSN： 1532-6535|103|3|395-395

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.3, 2018-03, pp. : 395-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Biomedical Paradigm and the Nobel Prize: Is It Time for a Change?

By Foss L.

Theoretical Medicine, Vol. 19, Iss. 6, 1998-12 ,pp. : 621-644

Springer Publishing Company

Access to resources Recommend Favorite

A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide

By Gluck Paul A. Gluck Joan C.

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1075-1084

Informa Healthcare

Access to resources Recommend Favorite

Gender Differences in Drug Bioequivalence: Time to Rethink Practices

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 260-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral challenge without skin tests in children with non‐severe beta‐lactam hypersensitivity: Time to change the paradigm?

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 28, Iss. 8, 2017-12 ,pp. : 724-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications

By Sathyan Gayatri Guo Cindy Sivakumar Krishna Gidwani Shalini Gupta Suneel

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1961-1968

Informa Healthcare

Access to resources Recommend Favorite